AC
CDNA icon

AMS Capital’s CareDx CDNA Stock Holding History

AMS Capital’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-24,082
Closed -$695K – 23
2018
Q3 		$695K Buy
+24,082
New +$451K 0.57% 35

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

AMS Capital's CDNA Position: Q4 2018 in Review

AMS Capital sold out of CareDx (CDNA) in Q4 2018, closing a stake of 24,082 shares — an estimated $695K sold.

AMS Capital first reported a position in CDNA in Q3 2018 and held it in 1 quarter. The position peaked at $695K in Q3 2018. 148 funds tracked by Wall St. Rank hold CDNA as of Q4 2018.

  • AMS Capital reported no remaining CareDx position as of Q4 2018 after selling out during the quarter.
  • AMS Capital sold 24,082 CareDx shares in Q4 2018, an estimated $695K.
  • AMS Capital first reported a position in CareDx in Q3 2018 and held it in 1 quarter.
  • AMS Capital's CareDx position peaked at $695K in Q3 2018.
  • 148 funds tracked by Wall St. Rank held CareDx as of Q4 2018.

Based on AMS Capital's 13F filing for Q4 2018, filed 29 Jan 2019.